Bortezomib,Pirarubicin,Dexamethasone
SHCZH-2010-CT-001
Approved small_molecule active
Quick answer
Bortezomib,Pirarubicin,Dexamethasone for Multiple Myeloma is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Multiple Myeloma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active